Release Date: 13/11/12 09:05 Summary: Daily share buy-back notice - Appendix 3E Price Sensitive: No Download Document 172.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%